Corpus ID: 51903132

Safety And Efficacy of Unani Compound Drug in Helicobacter Pylori Positive Antral Gastritis ( Warm-E-Meda Patients ) : A Controlled Study *

@inproceedings{Hilal2017SafetyAE,
  title={Safety And Efficacy of Unani Compound Drug in Helicobacter Pylori Positive Antral Gastritis ( Warm-E-Meda Patients ) : A Controlled Study *},
  author={R. Hilal and M. Fatimah and A. Ismail and I. Aziz and T. Ali},
  year={2017}
}
  • R. Hilal, M. Fatimah, +2 authors T. Ali
  • Published 2017
  • Warm-e-meda/gastritis is the prime concern in unani medicine and unani physicians emphasized on better functioning of stomach/meda. Acute gastritis, chronic gastritis, peptic ulcer disease, atrophic gastritis, gastric carcinoma, primary gastric B-cell lymphoma are some of the manifestation of H. pylori infection. An appreciable number of unani mufrad (single) and murakkab (compound) drugs are used to treat them. In this study we evaluate the efficacy of a unani compound drug in endoscopically… CONTINUE READING

    Tables from this paper.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 86 REFERENCES
    UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION
    • 4,771
    • PDF
    Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
    • 1,082
    • PDF
    Short‐term low‐dose triple therapy for the eradication of Helicobacter pylori
    • 327